Introduction
Resveratrol (3,5,4'-trihydroxystilbene, RSVL) is a phytoalexin produced by plants in response to damage, particularly in grapevines and peanuts.
1,2 RSVL has been shown to be a non-flavonoid phytoestrogen, and to act as an estrogen receptor agonist in MCF-7 cells transiently transfected with estrogen-responsive reporter constructs. 3 RSVL has similar effects in breast cancer cells expressing mutant and wild-type estrogen receptors. 4 Levenson et al 5 found that RSVL acted as an estrogen receptor agonist in breast cancer cells stably transfected with estrogen receptor . RSVL can modulate nitric oxide (NO) levels by its action on both endothelial nitric oxide synthase (eNOS) and cytokine-inducible nitric oxide synthase (iNOS). RSVL can cause NOmediated relaxation of precontracted endothelium-intact rat aorta through an increase of NO via eNOS. [6] [7] [8] [9] RSVL decreased Ca 2+ sensitivity but did not affect KCl-stimulated intracellular Ca 2+ increases in vascular smooth muscle of rat aorta. 10 RSVL also increases the amount of cGMP in sheep coronary arteries. This triggers vasorelaxant responses even in endothelium-disrupted arteries. 11 RSVL prevented bradykinin-induced contraction of rat urinary bladder smooth muscle by the inhibition of Ca 2+ influx. 12 Wang et al 13 showed that RSVL had an inhibitory effect on guinea pig gallbladder contractility. The present study determined which mechanisms mediated the relaxation effect of RSVL on cholecystokinin octapeptide (CCK) and KCl-induced tension in male guinea pig gallbladder strips.
M aterials and M ethods
The Animal Care Committee-Health Sciences of the University of Alberta approved the experiments performed by issuing protocol number (#275) on February 6, 2014. The experiments used male Hartley guinea pigs (200-375 g body weight) which were killed by decapitation. The gallbladder was removed, cleansed, and placed in Krebs-Henseleit solution that was gassed with 95% O 2 and 5% CO 2 . The composition of the KrebsHenseleit solution was NaCl, 115 mM; KCl, 5 mM CaCl 2 , 2.1 mM; MgSO 4 , 1.2 mM; NaH 2 PO 4 , 1.2 mM; NaHCO 3 , 25 mM; and glucose, 11 mM. Strips (1.5 × 0.5 cm) were made from each gallbladder which were maintained in Sawyer-Bartlestone chambers filled with Krebs-Henseleit solution, maintained at 37 o C, and gassed with 95% O 2 and 5% CO 2 . An optimum resting tension of 0.7 g was determined previously and used in the study. 14, 15 A Grass 7D polygraph (Grass Instruments Co., Quincy MA, USA) and Grass FT03 force displacement transducers were used to measure the force developed by the gallbladder strips. Isolated strips were equilibrated in the chambers for 45 minutes prior to determining their suitability for use. Each chamber had 2 M (final concentration) of atropine added in every experiment, 3 minutes prior to 1 nM CCK. The tension measurement was followed by 3 changes of Krebs-Henseleit solution. The test was repeated twice with 25 minutes between tests. A repeatable minimum active tension of 0.5 g had to be generated by the strips before use. All agents used were added directly to the chambers. All concentrations are reported as the final concentration in the chambers.
Several series of experiments were performed to examine the effects of RSVL on the tension generated by the gallbladder strips. CCK (1 nM) produced a stable long lasting tension after 3 minutes. This steady tension lasted at least 10 mintes. 14, 15 In order to determine if RSVL could relax CCK-or KCl-induced tension, concentration response curves were generated. The strips were exposed to 1 concentration of RSVL (10, 50, 100, or 250 M) , the response was observed until the relaxation reached a steady level (approximately 5 minutes), the Krebs-Henseleit solution was changed 3 times, and the strips were allowed to recover for 30 minutes before testing different concentrations of RSVL. The concentration of RSVL (75 M) was selected for use in subsequent experiments as it produced a reproducible relaxation. The same procedure was followed to generate a concentration response curve using 40 mM KCl instead of 1 nM CCK. The use of KCl to directly depolarize smooth muscle is a standard procedure. The concentration of each blocker used in the experiments was 5 times the half maximal inhibitory concentration (IC 50 ). In order to determine if the Ca 2+ released from the endoplasmic reticulum mediated the RSVL-induced relaxation 2-aminoethoxydiphenylborane (2-APB,125 M), a cell permeable inhibitor of inositol 1,4,5-triphosphate (IP 3 )-induced Ca 2+ release, was added to the chambers 10 minutes prior to the CCK. The CCK was then added to the chambers. When the tension reached a steady level, 75 M RSVL was added to the chambers. The amount of relaxation was observed. The amount of relaxation observed when RSVL only was used, was then compared to the amount of relaxation observed when the strips were treated with 2-APB and RSVL. This procedure was followed with each agent used. Protein kinase A inhibitor 14-22 amide myristolated (a protein kinase inhibitor, PKA-IM; 180 nM), KT5823 (a protein kinase G [PKG] inhibitor, 585 nM), and genistein (a tyrosine kinase inhibitor, 10 M) were added to the chambers 5 minutes prior to the addition of CCK.
The PKC inhibitors, chelerythrine Cl − (5 M) and bisindolymaleimide IV (BisIV, 0.5 M), were used together to determine the effects of PKC on RSVL-induced relaxation of CCK-or KCl-induced tension. They were added to the chambers 5 minutes prior to either CCK or KCl. N G -methyl-L-arginine acetate salt (20 M) was used to determine if NO mediated the RSVL -induced relaxation. Fulvestrant (10 M), an estrogen receptor blocker, was used to determine if RSVL might act via estrogen receptor activation.
In order to determine if RSVL inhibited extracellular Ca 2+ entry, 40 mM KCl was used to induce tension in the strips. After the amount of tension generated by the 40 mM KCl was recorded, the Krebs-Henseleit solution was changed 3 times and the strips allowed to equilibrate for 25 minutes. The 75 M RSVL was then added to the chambers 3 minutes prior to the addition of 40 mM KCl. The amount of tension generated was recorded and compared to that observed when the KCl was added to the chambers with no RSVL. The same experiments were performed using CCK, i.e., adding RSVL 3 minutes prior to the addition of CCK.
The following agents were purchased from Sigma (St. Louis, MO, USA): CCK, atropine, N G -methyl-L-arginine acetate salt, fulvestrant, and bisindolymaleimide IV. The following agents were purchased from Calbiochem (LaJolla, CA, USA): PKA-IM, KT5823, chelerythrine Cl − , genistein, and 2-APB. Trans-resveratrol was purchased from Cayman Chemical (Ann Arbor, MI, USA). All agents were dissolved in either distilled water or dimethyl sulfoxide. The amount of dimethyl sulfoxide (10 L) added to the chambers was determined to have no effect on the strips.
Statistical Methods
Statistical comparisons were done using the paired t test. Results are expressed as mean ± SE Differences among mean values with P < 0.05 were considered significant. The number of gallbladders (animals) used in each experiment are indicated by "n". Each gallbladder was used to prepare 4 strips; hence, an n of 4 means up to 16 strips were used. When the strips were treated with 2-aminoethoxydiphenylborane (2-APB), there was a significant (*P < 0.05) decrease in the amount of relaxation observed between the strips not treated and treated with 2-APB (n = 6). When the PKA inhibitor 14-22 amide myristolated (PKA-IM), was used, no significant effect was observed on the amount of cholecystokinin octapeptide (CCK)-induced tension; nor was there a significant effect on the amount of RSVL-induced relaxation (n = 6). 
Results
RSVL induced a concentration dependent relaxation in both CCK-and KCl-induced tension (Fig. 1) . RSVL at 10 M and 100 M significantly (P < 0.01, n = 20) relaxed the CCK-induced tension more than KCl-induced tension. When 75 M or 250 M RSVL was used, there was no significant difference in the amount of RSVL-induced relaxation when CCK and KCl were compared. There was no significant difference between the amount of CCK-induced tension and the KCl-induced tension (1 nM CCK, 0.86 ± 0.05 g vs 40 mM KCl, 0.88 ± 0.06 g; n = 8).
The use of 2-APB, an inhibitor of IP 3 -induced Ca 2+ release, caused a significant (P < 0.001) decrease in the amount of CCK-induced tension (0.79 ± 0.05 g vs 0.31 ± 0.03 g, n = 6). When the strips were treated with 2-APB, there was a significant (P < 0.05) decrease in the amount of relaxation observed between the strips not treated and treated with 2-APB (59.7 ± 3.6% vs 45.9 ± 5.6%, n = 6; Fig. 2 ). When PKA-IM was used, no significant effect was observed on the amount of CCK-induced tension (0.75 ± 0.05 g vs 0.8 ± 0.05 g, n = 5); nor was there a significant effect on the amount of RSVL-induced relaxation (45.7 ± 4.5% vs 46.5 ± 5.0%, n = 5). Treatment of the strips with KT5823, a PKG blocker, significantly (P < 0.01) increased the amount of CCK-induced tension (0.77 ± 0.06 g vs 0.86 ± 0.06 g, n = 4). KT5823 did not have a significant effect on the amount of RSVL-induced relaxation of CCK-induced tension (48.1 ± 4.0% vs 50.3 ± 5.2%, n = 4; Fig. 3 ). Genistein significantly (P < 0.01) increased effect on the amount of RSVL-induced relaxation of CCK-induced tension (53.4 ± 2.2% vs 61.8 ± 3.8%, n = 4; Fig. 3 ). There was no significant difference in the amount of CCK-induced tension (0.79 ± 0.06 g vs 0.74 ± 0.06 g).
When the PKC blockers, BisIV and chelerythrine Cl − were used in combination, a significant increase (P < 0.05) in the amount of RSVL-induced relaxation (61.8 ± 3.5% vs 73.7 ± 5.6%, n = 4; Fig. 4 ) was observed; however, there was no significant effect on the amount of CCK-induced tension (0.64 ± 0.04 g vs 0.68 ± 0.04 g).
The use of N G -methyl-L-arginine acetate salt, a NO synthase blocker, did not have a significant effect on either the CCK-induced tension or the RSVL-induced relaxation (48.1 ± When RSVL (75 M) was added to the chambers 3 minutes prior to the addition of KCl there was a significant decrease (*P < 0.001) in the amount of tension generated (n = 5). When 75 M RSVL was added to the chambers 3 minutes prior to the addition of CCK (1 nM), there was a significant (*P < 0.001) decrease in the amount of tension generated (n = 3).
3.4% vs 44.6 ± 3.2%, n = 4). The use of the estrogen receptor blocker fulvestrant did not have a significant effect on the amount of CCK-induced tension (CCK + RSVL, 0.84 ± 0.09 g vs fulvestrant + CCK + RSVL, 0.81 ± 0.08 g; n = 5). Fulvestrant also had no significant effect in the amount of RSVL-induced relaxation (CCK + RSVL, 50.9 ± 3.8% vs fulvestrant + CCK + RSVL, 50.2 ± 5.2%; n = 5).
When RSVL was added to the chambers 3 minutes prior to the addition of KCl, there was a significant decrease (P < 0.001) in the amount of tension generated (0.85 ± 0.06 g vs 0.42 ± 0.04 g, n = 5. Fig. 5 ). When 75 M RSVL was added to the chambers 3 minutes prior to the addition of CCK (1 nM), there was a significant (P < 0.001) decrease in the amount of tension generated (0.56 ± 0.05 g vs 0.34 ± 0.05 g, n = 3; Fig. 5 ).
Discussion
RSVL is a non-flavonoid phytoestrogen that can act as an estrogen receptor agonist in MCF-7 cells and breast cancer cells. 3, 4 Strips of either male or female guinea pig gallbladder strips are sensitive to both 17 -estradiol and progesterone. Both 17 -estradiol and progesterone relaxed both CCK-and KCl-induced tensions using different signaling pathways. [16] [17] [18] The current experiments demonstrated that RSVL relaxed both CCK-and KCl-induced tensions in a concentration-dependent manner. The use of fulvestrant demonstrated that this effect of RSVL was not mediated through estrogen receptors which had been suggested by other researchers. [3] [4] [5] El Mowafy 11 showed that RSVL increased cGMP in sheep coronary arteries which led to an endothelium-independent vasodilation. In the guinea pig gallbladder strips the use of KT5823, a PKG antagonist, had no significant effect on the amount of RSVL-induced relaxation. RSVL acted through NO release from endothelium-intact blood vessels. [6] [7] [8] [9] The use of N G -methyl-L-arginine acetate salt reported here showed that inhibiting NO synthase had no significant effect on the RSVL-induced relaxation.
BisIV and chelerythrine Cl − are PKC inhibitors. Using BisIV and chelerythrine Cl − in together produced consistent results. 14, 15 The PKC inhibitors significantly increased the amount of RSVL-induced relaxation. Wu et al, 19 using the patchclamp technique, demonstrated that gallbladder contraction required increasing Ca 2+ influx through L-type Ca 2+ calcium channels via a PKC pathway. Zhu et al 20 showed that sulfated CCK prompted contraction of guinea pig proximal colon smooth muscle strips via activation of the IP 3 -PKC signal transduction pathway. Activation of PKC leads to an increase in L-channel opening which would lead to a decrease in RSVL-induced relaxation. Blocking PKC with BisIV and chelerythrine Cl − would lead to a decrease in L-channel opening which would lead to an increase in RSVL-induced relaxation. This is what was observed in the guinea pig gallbladder strips. In addition, using PKA-IM did not have a significant effect on the amount of RSVL-induced relaxation. Thus, the PKA did not mediate the RSVL-induced relaxation. Protein tyrosine kinase may have a role in gallbladder smooth muscle contractility. In guinea pig gallbladder strips, genistein, a protein tyrosine kinase inhibitor, significantly decreased the progesterone-induced relaxation, with no effect on the CCK-induced tension. 16 Alcón et al 21 demonstrated that vanadate activated the tyrosine kinase pathway in guinea pig gallbladder smooth muscle. When genistein was used in the current study, genistein significantly increased the amount of RSVL-induced relaxation. Genistein has been shown to inhibit peristalsis in guinea pig small intestine by inhibiting intracellular signaling cascades involving protein kinases that act on the contractile apparatus in smooth muscle. 22 The genistein-induced inhibition of protein tyrosine kinase in addition to the actions of RSVL may have led to the increased relaxation. mobilization from the sarcoplasmic reticulum via IP 3 channels. KCl was used to directly depolarize the gallbladder strips. RSVL, when added to the chambers prior to KCl, significantly decreased the amount of KCl-induced tension. Therefore, blocking of L-type Ca 2+ channels mediated part of the RSVL-induced relaxation. RSVL had the same effect on CCK-induced tension. Since RSVL significantly decreased the amount of both KCl-and CCK-induced tension when added to the chambers prior to either agonist, it suggested that RSVL exerts its effect in part by blocking L-type Ca 2+ channels. It may also block intracellular Ca 2+ release. Using 2-APB, an inhibitor of IP3-induced Ca 2+ release, caused a significant decrease in the amount of RSVL-induced relaxation. This suggested that part of the RSVL effect was mediated through intracellular Ca 2+ release.
The sustained phase of CCK-induced tension requires extracellular Ca 2+ entry. 16 The current study demonstrated that RSVL relaxed both CCK-and KCl-induced tension in male guinea pig gallbladder strips. No second messenger systems studied produced a significant effect on the RSVL-induced relaxation. The adding of RSVL to the in vitro chambers before either CCK or KCl produced a decrease in the amount of tension generated which was significant. If the amount of tension generated by either agonist is significantly decreased when RSVL is added before either CCK or KCl and no second messenger system had an effect on the RSVL-induced relaxation, which was significant, then it can be concluded that RSVL exerts its effects by blocking L-type Ca 2+ channels. The results of these experiments are similar to those reported for vascular smooth muscle cells and strips. 17, 27 In conclusion, the relaxation effect of RSVL was mediated primarily by its effects on both L-type Ca 2+ channels and intracellular Ca 2+ release.
